Hypertension in goldminers

South African Medical Journal

Volumn 102, Issue 1, 2012, Pages 30-33

  Maepe, L M ^a   Outhoff, K ^b  

^a Sir Albert Medical Centre   (South Africa)

^b UNIVERSITY OF PRETORIA   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CENTRAL MUSCLE RELAXANT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT;

ADULT; ARTICLE; BLOOD PRESSURE MEASUREMENT; BLOOD PRESSURE REGULATION; CARDIOVASCULAR RISK; DIASTOLIC BLOOD PRESSURE; ETHNICITY; HEALTH CARE FACILITY; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MINER; MORBIDITY; MORTALITY; OCCUPATIONAL HEALTH; PREVALENCE; PRIMARY HEALTH CARE; RETROSPECTIVE STUDY; RISK FACTOR; SOUTH AFRICA; SYSTOLIC BLOOD PRESSURE;

ADULT; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE MONITORING, AMBULATORY; CORONARY DISEASE; CROSS-SECTIONAL STUDIES; DRUG THERAPY, COMBINATION; FEMALE; GOLD; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; MINING; OUTCOME ASSESSMENT (HEALTH CARE); RETROSPECTIVE STUDIES; SECONDARY PREVENTION; SOUTH AFRICA;

EID: 84255199914     PISSN: 02569574     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. He J, Whelton PK. Epidemiology and prevention of hypertension. Med Clin North Am 1997;81:1077-1097.
2. Chobanion AV, Bakris GL, Back HR, et al. Seventh Report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure. Hypertension 2003;42:1206-1252.
3. Poulter N. Global risk of cardiovascular disease. Heart 2003;89(2):ii2-ii5.
4. Kearney PM, Whelton M, Reynolds K, Muntrer P, Wholton PK, He J. Global burden of hypertension: analysis of worldwide data. Lancet 2005;365:217-223.
5. Ezzati M, Lopez AD, Rodgers A, van der Hoorn S, Murray CJ. Selected major risk factors and global and regional burden of disease. Lancet 2002;360:1347-1360.
6. Li H, Meng Q, Wang XS, Briggs E, Hiller JE. Prevalence, awareness, treatment and control of hypertension in rural China. J Hypertens 2010;28:432-438.
7. Vasan RS, Beiser A, Seshadri S, et al. Residual lifetime risk for developing hypertension in middle-aged women and men. The Framingham Heart Study. JAMA 2002;287:1003-1010.
8. MacMahon S, Rodgers A. Blood pressure, antihypertensive treatment, and stroke risk. J Hypertens 1994;12(10):S5-S14
9. Collins R, MacMahon S. Blood pressure, antihypertensive drug treatment and the risk of stroke and of coronary heart disease. Br Med Bull 1994;50:272-298.
10. Kaufman JS, Rotimi CN, Brieger WR, et al. The mortality risk associated with hypertension: prospective study in rural Nigeria. J Hum Hypertens 1996;10:461-464.
11. Connor M, Rheeder P, Bryer A, et al. The South African risk in general practice study. S Afr Med J 2005:95:334-339.
12. Fray JC, Douglas JG, eds. Pathophysiology of Hypertension in Blacks. Oxford: Oxford University Press, 1993.
13. Hajjar I, Kotchen TA. Trends in prevalence, awareness, treatment, control of hypertension in the United States, 1988-2000. JAMA 2003;290:199-206.
14. Seedat, YK. Hypertension in black South Africans. J Hum Hypertens 1999;13:96-103.
15. JNC-7.The 7th Report of Joint National Committee on prevention, detection, evaluation and treatment of high blood pressure. JAMA 2003;289:2560-2572.
16. Sliwa K, Wilkinson D, Hansen C, et al. Spectrum of heart disease and risk factors in a black urban population in South Africa (the Heart of Soweto Study): a cohort study. Lancet 2008;371:915-922.
17. Cooper R, Rotomi C, Ataman S, et al. The prevalence of hypertension in seven populations of West African origin. Am J Public Health 1997;87:160-168.
18. National Institute for Health and Clinical Excellence. Hypertension: management of hypertension in adults in primary care. http://guidance.nice.org.uk/CG127 (accessed 1 September 2011).
19. Cushman WC, Ford CE, Cutler JA, et al. Success and predictors of blood pressure control in diverse North American settings. The Antihypertensive and Lipid Lowering Treatment to Prevent Heart Attack Trial. J Clin Hypertens 2002:4:393-404.
20. Black HR, Elliot WJ, Neaton JD, et al. Baseline characteristics and early blood pressure in the CONVINCE trial. Hypertension 2001;37:12-18.
21. Seedat YK, Croasdale MA, Milne FJ, et al. (Joint National Hypertension Guideline Working Group 2006). South African Hypertension Guideline 2006. S Afr Med J 2006;96(4):337-362.